日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/02/27 | 1,235 | 1,242 | 1,214 | 1,222 | +7 | +0.6% | 314,000 |
2013/02/26 | 1,215 | 1,227 | 1,210 | 1,215 | ±0 | ±0% | 156,000 |
2013/02/25 | 1,197 | 1,219 | 1,197 | 1,215 | +18 | +1.5% | 86,000 |
2013/02/22 | 1,192 | 1,210 | 1,192 | 1,197 | -14 | -1.2% | 110,000 |
2013/02/21 | 1,186 | 1,224 | 1,186 | 1,211 | +19 | +1.6% | 209,000 |
2013/02/20 | 1,174 | 1,198 | 1,173 | 1,192 | +8 | +0.7% | 146,000 |
2013/02/19 | 1,185 | 1,195 | 1,180 | 1,184 | -2 | -0.2% | 119,000 |
2013/02/18 | 1,176 | 1,191 | 1,176 | 1,186 | +12 | +1% | 116,000 |
2013/02/15 | 1,171 | 1,185 | 1,171 | 1,174 | ±0 | ±0% | 185,000 |
2013/02/14 | 1,173 | 1,182 | 1,165 | 1,174 | -6 | -0.5% | 141,000 |
2013/02/13 | 1,191 | 1,193 | 1,174 | 1,180 | -14 | -1.2% | 184,000 |
2013/02/12 | 1,210 | 1,236 | 1,192 | 1,194 | +16 | +1.4% | 300,000 |
2013/02/08 | 1,169 | 1,178 | 1,134 | 1,178 | +54 | +4.8% | 315,000 |
2013/02/07 | 1,139 | 1,140 | 1,116 | 1,124 | -6 | -0.5% | 100,000 |
2013/02/06 | 1,138 | 1,140 | 1,100 | 1,130 | +23 | +2.1% | 116,000 |
2013/02/05 | 1,100 | 1,127 | 1,100 | 1,107 | -9 | -0.8% | 95,000 |
2013/02/04 | 1,130 | 1,132 | 1,103 | 1,116 | -13 | -1.2% | 186,000 |
2013/02/01 | 1,149 | 1,155 | 1,126 | 1,129 | -19 | -1.7% | 156,000 |
2013/01/31 | 1,148 | 1,153 | 1,123 | 1,148 | -15 | -1.3% | 182,000 |
2013/01/30 | 1,144 | 1,166 | 1,144 | 1,163 | +26 | +2.3% | 117,000 |
2013/01/29 | 1,140 | 1,153 | 1,137 | 1,137 | -1 | -0.1% | 70,000 |
2013/01/28 | 1,156 | 1,158 | 1,131 | 1,138 | -6 | -0.5% | 121,000 |
2013/01/25 | 1,169 | 1,169 | 1,130 | 1,144 | -17 | -1.5% | 214,000 |
2013/01/24 | 1,101 | 1,165 | 1,100 | 1,161 | +54 | +4.9% | 327,000 |
2013/01/23 | 1,088 | 1,130 | 1,083 | 1,107 | +15 | +1.4% | 186,000 |
2013/01/22 | 1,090 | 1,110 | 1,077 | 1,092 | -5 | -0.5% | 161,000 |
2013/01/21 | 1,089 | 1,104 | 1,086 | 1,097 | +3 | +0.3% | 118,000 |
2013/01/18 | 1,072 | 1,101 | 1,061 | 1,094 | +47 | +4.5% | 294,000 |
2013/01/17 | 1,096 | 1,099 | 1,036 | 1,047 | -50 | -4.6% | 330,000 |
2013/01/16 | 1,085 | 1,100 | 1,074 | 1,097 | +12 | +1.1% | 203,000 |
2013/01/15 | 1,099 | 1,111 | 1,077 | 1,085 | ±0 | ±0% | 165,000 |
2013/01/11 | 1,049 | 1,098 | 1,045 | 1,085 | +50 | +4.8% | 277,000 |
2013/01/10 | 1,018 | 1,035 | 1,013 | 1,035 | +22 | +2.2% | 106,000 |
2013/01/09 | 999 | 1,019 | 999 | 1,013 | +7 | +0.7% | 88,000 |
2013/01/08 | 1,000 | 1,019 | 998 | 1,006 | +6 | +0.6% | 119,000 |
2013/01/07 | 1,012 | 1,017 | 996 | 1,000 | -2 | -0.2% | 173,000 |
2013/01/04 | 993 | 1,003 | 987 | 1,002 | +29 | +3% | 95,000 |
2012/12/28 | 976 | 983 | 972 | 973 | -9 | -0.9% | 112,000 |
2012/12/27 | 990 | 993 | 982 | 982 | -9 | -0.9% | 102,000 |
2012/12/26 | 994 | 995 | 985 | 991 | +3 | +0.3% | 164,000 |
2012/12/25 | 992 | 994 | 983 | 988 | +15 | +1.5% | 145,000 |
2012/12/21 | 974 | 982 | 969 | 973 | +4 | +0.4% | 196,000 |
2012/12/20 | 972 | 983 | 967 | 969 | -3 | -0.3% | 193,000 |
2012/12/19 | 958 | 973 | 947 | 972 | +19 | +2% | 252,000 |
2012/12/18 | 970 | 973 | 953 | 953 | -13 | -1.3% | 178,000 |
2012/12/17 | 974 | 984 | 963 | 966 | -4 | -0.4% | 111,000 |
2012/12/14 | 974 | 988 | 966 | 970 | +2 | +0.2% | 219,000 |
2012/12/13 | 980 | 980 | 965 | 968 | +3 | +0.3% | 150,000 |
2012/12/12 | 993 | 996 | 960 | 965 | -13 | -1.3% | 194,000 |
2012/12/11 | 1,003 | 1,003 | 977 | 978 | -10 | -1% | 119,000 |
3001~
3050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム